Claudia Styslinger | Investor Relations |
Russell Ellison | President, Chief Executive Officer & Director |
Tim Chole | Vice President, Marketing |
Russell Skibsted | Executive Vice President, Chief Financial Officer & Chief Business Officer |
Brandon Folkes | Cantor Fitzgerald & Co. |
Blair Cohen | H.C. Wainwright & Co. |
Disclaimer: *NEW* We are providing this transcript version in a raw | machine-assisted format and it is unaudited. Please reference the audio for any questions on the content. A standard transcript will be available later on the site per our normal procedure. Please enjoy this timely version in the interim. |
[00:00:03] Good afternoon, ladies and gentlemen, and welcome to the Rockwell Medical 2020 Q3 results call as a reminder this conference call is being recorded at this time. I'd like to introduce Claudia Styslinger Investor Relations. Please go ahead.
[00:01:34] Welcome to Rockwell Medicals third quarter Twenty Stys linger earnings results call, this is Claudia Stifling of Aagot Partners, the investor relations representative for Rockwell Medical.
Joining me from Rockwell Medical.